Toomas Podar

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

John Dormandy, B Charbonnel, D.J.A. Eckland et al. · The Lancet · 2005 · 4.1K citations · Full text

Diabetes Management, Cardiovascular Disease, Health Policy +10

Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder.

Jakov Shlik, Anu Aluoja, Veiko Vasar et al. · PubMed · 1997 · 117 citations · Full text

Tetrapeptide Challenge, Heart Rate, Psychiatry +14

Cumulative Incidence of Type 1 Diabetes in 10,168 Siblings of <i>F</i>innish Young-Onset Type 1 Diabetic Patients

Valma Harjutsalo, Toomas Podar, Jaakko Tuomilehto · Diabetes · 2005 · 82 citations · Full text

Evidence for importance of gender and birth cohort for risk of IDDM in offspring of IDDM parents

Jaakko Tuomilehto, Toomas Podar, Eva Tuomilehto‐Wolf et al. · Diabetologia · 1995 · 71 citations · Full text

Birth Cohort, Genetic Epidemiology, Reproductive Health +7

Increasing incidence of childhood-onset Type I diabetes in 3 Baltic countries and Finland 1983–1998

Toomas Podar, A Solntsev, M. Karvonen et al. · Diabetologia · 2001 · 62 citations · Full text

Baltic Countries, Diabetes Management, Diabetes Epidemiology +10